Key result
The choice of anticoagulation during continuous renal replacement therapy depends on patient characteristics and institutional protocols, with regional citrate anticoagulation becoming increasingly preferred due to its lower bleeding risk.
Why the study?
Although ensuring circuit patency is essential during continuous renal replacement therapy and various anticoagulation alternatives exist, there is no worldwide consensus regarding their use.
This review highlights that while unfractionated heparin is the traditional anticoagulant for CRRT, regional citrate and low molecular weight heparins are increasingly preferred for their safety, though therapy must be individualized.
Answers are grounded in this paper and cite their sources.
Supports individualized CRRT anticoagulation; leaves open optimal agent selection pending randomized trials.
Renal replacement therapy in Intensive Care Units is a daily practice worldwide. Ensuring blood flow continuum within extracorporeal circuit is one of the basic tasks during therapy. Unfractionated heparin remains the most popular anticoagulant used. Alternatives, such as low molecular weight heparins, prostacyclin, fondaparinux, or regional use of citrate or nafomostate mesilate are also gaining ground, mainly due to their safety profile. Still, there is no worldwide consensus about their use. Systemic, regional, combined or no coagulation at all; the final choice depends on the patients' characteristics and co-morbidities, as well as institutional and organizational protocols, equipment availability and staff education. This article presents a review of the current modalities for anticoagulation during continuous renal replacement therapy.
No takes yet. Share an insight, caveat, or question.
Aslanidis et al. (2019) conducted a review in Acute renal dysfunction requiring continuous renal replacement therapy. Anticoagulation modalities was evaluated. The choice of anticoagulation during continuous renal replacement therapy depends on patient characteristics and institutional protocols, with regional citrate anticoagulation becoming increasingly preferred due to its lower bleeding risk.
Synapse has enriched 10 related papers. Consider them for comparative context: